Recursion Pharmaceuticals Inc. (RXRX) reported its third-quarter 2025 earnings, revealing a mixed performance with an EPS of -$0.36, slightly surpassing the forecast of -$0.37. However, the company ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...
Recursion Pharmaceuticals, Inc ((RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, Inc. recently held its earnings call, which conveyed an ...
WASHINGTON (AP) — Mary Sheffield won the race for Detroit mayor on Tuesday, defeating Solomon Kinloch Jr. to become the first woman elected to lead the city. Sheffield, the Detroit City Council ...
The newly described microbe represents a world of parasitic, intercellular biodiversity only beginning to be revealed by ...
article argues that the pervasive censorship of 'mainstream' AI models like Claude and ChatGPT necessitates the work of ...
The former Today show's daughters looked over the moon to be back with dad Social media users were delighted to see the family hanging out together More, Hoda reveals heartbreaking moment she realized ...